Table 3.
Properties of the selected T-cell epitopes for the final vaccine construction
| UniProtKB ID | Sequence | VaxiJen score | Immunogenicity score | Toxicity | pI | Molecular weight | HLA Class I Alleles |
|---|---|---|---|---|---|---|---|
| P0DTC8 | EPKLGSLVV | 1.38 | -0.19 | Non-Toxin | 6.35 | 941.27 | HLA-B*53:01,HLA-B*35:01,HLA-B*07:02,HLA-B*54:01,HLA-B*51:01,HLA-B*51:02 |
| P0DTC9 | NFKDQVILL | 1.17 | -0.02 | Non-Toxin | 6.19 | 1089.44 | HLA-A*02:01,HLA-A*02:02,HLA-A*02:03,HLA-A*02:04,HLA-A*02:05,HLA-A*02:06,HLA-A*68:02,HLA-A*24:02,HLA-B*38:01 |
| P0DTC9 | SSRSSSRSR | 1.23 | -0.52 | Non-Toxin | 12.31 | 1009.14 | HLA-A*33:01,HLA-A*11:01,HLA-A*31:01,HLA-A*03:01,HLA-A*68:01,HLA-A*66:01 |
HLA: human leukocyte antigen